Yazar "Aysolmaz G." seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Delayed neuropathy due to organophosphate intoxication: Case report [Organofosfat ze? irlenmesine ba?li gel? işen ge? iki?iş Nöropa? i (Olgu sunumu)]
    (2004) Çelik J.; Aysolmaz G.; Ökesli S.
    Organophosphorus compound intoxication is common in our country. Some patients subsequently have organophosphate-induced delayed neuropathy. This neuropathy results in damage of both peripheral and central nervous systems. In this case report, a 56 year-old woman attempted suicide by taking approximately 950 mg kg-1 dimethyl-2,2-dichloro vinyl phosphate (DDVP)(dichlorvos) orally. After a muscarinic and cholinergic syndrome lasting three days, she developed a purely motor distal axonal polyneuropathy on the 16th day. Polyneuropathy symptoms revealed full recovery on the upper extremities and small recovery on the lower extremities at the end of the 4th month. In conclusion, organophosphate induced delayed polyneuropathy is an important cause of morbidity and is not a well known clinical presentation as acute toxicity.
  • Küçük Resim Yok
    Öğe
    The effects of the administration of suhfacial levohupivacaine infusion with the ON-Q pain pump system on postoperative analgesia and tramadol consumption in cesarean operations [Sezaryen cerrahisinde on-q a?ri pompa sistemi ile uygulanan subfasiyal levobupivakain infüzyonunun postoperatif analjezi ve tramadol tüketimine etkisi]
    (2010) Tuncer S.; Aysolmaz G.; Reisli R.; Erol A.; Yalçin N.; Yosunkaya A.
    Objectives: In this study, the effects of administration of suhfacial levobupivacaine infusion with the ON-Q pain pump system were investigated in elective cesarean operations for postoperative pain control and tramadol-sparing effect. Methods: Fifty ASA I-II patients scheduled for cesarean operation were enrolled into this study. Patients were randomly divided into two groups: Group I served as a control group, without the ON-Q pain pump system, whereas Group II received the ON-Q pain pump system with subfacial 0.25% levobupivacaine infusion for 24 hours at 4 ml/hour. All patients received a standard anesthetic protocol At the end of the surgery, all patients received tramadol i.v. via a PCA (Patient Controlled Analgesia) device. Pain scores were assessed at 2, 6, 12 and 24 hours postoperatively. Tramadol consumption and adverse effects were noted in the first 24 hours following surgery. Results: The pain scores were significantly lower in the levobupivacaine group when compared with the control group (p<0.05). The cumulative tramadol consumption was lower in the levobupivacaine group than in the control group (p<0.05). Group II used less antiemetic and had less postoperative nausea and vomiting and the difference was statistically significant (p<0.0S). Conclusion: No complication occurred as a result of the ON-Q pain pump system. Subfacial levobupivacaine infusion with the ON-Q pain pump system diminished postoperative pain and the need for tramadol use following cesarean operations.